| 0 |
DRUG INEFFECTIVE |
26 |
| 1 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
24 |
| 2 |
ASPARTATE AMINOTRANSFERASE INCREASED |
22 |
| 3 |
HEADACHE |
22 |
| 4 |
ALANINE AMINOTRANSFERASE INCREASED |
20 |
| 5 |
PRURITUS |
20 |
| 6 |
DIZZINESS |
18 |
| 7 |
FATIGUE |
15 |
| 8 |
NAUSEA |
14 |
| 9 |
DIARRHOEA |
12 |
| 10 |
ABDOMINAL DISTENSION |
11 |
| 11 |
ABDOMINAL PAIN |
11 |
| 12 |
HEPATIC ENZYME INCREASED |
10 |
| 13 |
ABDOMINAL PAIN UPPER |
9 |
| 14 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
8 |
| 15 |
VOMITING |
8 |
| 16 |
ALOPECIA |
6 |
| 17 |
OFF LABEL USE |
6 |
| 18 |
RASH |
6 |
| 19 |
ABDOMINAL DISCOMFORT |
5 |
| 20 |
DRUG-INDUCED LIVER INJURY |
5 |
| 21 |
FALL |
5 |
| 22 |
HYPERTRANSAMINASAEMIA |
5 |
| 23 |
THERAPY NON-RESPONDER |
5 |
| 24 |
BLOOD BILIRUBIN INCREASED |
4 |
| 25 |
DYSPHAGIA |
4 |
| 26 |
GLOMERULAR FILTRATION RATE DECREASED |
4 |
| 27 |
PRODUCT STORAGE ERROR |
4 |
| 28 |
THERAPY CESSATION |
4 |
| 29 |
TRANSAMINASES INCREASED |
4 |
| 30 |
ANXIETY |
3 |
| 31 |
ARTHRALGIA |
3 |
| 32 |
BACK PAIN |
3 |
| 33 |
CHEST DISCOMFORT |
3 |
| 34 |
CHROMATURIA |
3 |
| 35 |
EYE PRURITUS |
3 |
| 36 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
| 37 |
HEPATIC FAILURE |
3 |
| 38 |
HYPERTENSION |
3 |
| 39 |
PAIN IN EXTREMITY |
3 |
| 40 |
PRODUCT USE ISSUE |
3 |
| 41 |
RENAL FAILURE |
3 |
| 42 |
RENAL IMPAIRMENT |
3 |
| 43 |
TREMOR |
3 |
| 44 |
VISION BLURRED |
3 |
| 45 |
VISUAL IMPAIRMENT |
3 |
| 46 |
WEIGHT INCREASED |
3 |
| 47 |
ANKLE FRACTURE |
2 |
| 48 |
ASTHENIA |
2 |
| 49 |
AUTOIMMUNE HEPATITIS |
2 |
| 50 |
BILIRUBIN CONJUGATED INCREASED |
2 |
| 51 |
BLISTER |
2 |
| 52 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
2 |
| 53 |
BLOOD CREATININE INCREASED |
2 |
| 54 |
BLOOD IMMUNOGLOBULIN M INCREASED |
2 |
| 55 |
CARDIAC FAILURE |
2 |
| 56 |
CHOLESTASIS |
2 |
| 57 |
CONDITION AGGRAVATED |
2 |
| 58 |
CONFUSIONAL STATE |
2 |
| 59 |
CONSTIPATION |
2 |
| 60 |
CREATINE KINASE INCREASED |
2 |
| 61 |
DYSGEUSIA |
2 |
| 62 |
DYSPEPSIA |
2 |
| 63 |
DYSPNOEA |
2 |
| 64 |
EXPOSURE VIA BREAST MILK |
2 |
| 65 |
EYE IRRITATION |
2 |
| 66 |
FLUID RETENTION |
2 |
| 67 |
GAIT DISTURBANCE |
2 |
| 68 |
GALLBLADDER DISORDER |
2 |
| 69 |
HAEMOGLOBIN DECREASED |
2 |
| 70 |
HEPATIC STEATOSIS |
2 |
| 71 |
HEPATITIS |
2 |
| 72 |
INFECTION |
2 |
| 73 |
INJECTION SITE ERYTHEMA |
2 |
| 74 |
INSOMNIA |
2 |
| 75 |
LOSS OF CONSCIOUSNESS |
2 |
| 76 |
MYALGIA |
2 |
| 77 |
OEDEMA PERIPHERAL |
2 |
| 78 |
PAIN |
2 |
| 79 |
PERIPHERAL SWELLING |
2 |
| 80 |
PRODUCT DOSE OMISSION ISSUE |
2 |
| 81 |
SMALL INTESTINAL PERFORATION |
2 |
| 82 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
| 83 |
THROAT IRRITATION |
2 |
| 84 |
URTICARIA |
2 |
| 85 |
VERTIGO |
2 |
| 86 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
| 87 |
ACNE |
1 |
| 88 |
ACUTE KIDNEY INJURY |
1 |
| 89 |
ANAEMIA |
1 |
| 90 |
ANAPHYLACTIC REACTION |
1 |
| 91 |
APPETITE DISORDER |
1 |
| 92 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
| 93 |
BILE DUCT STENOSIS |
1 |
| 94 |
BILIARY OBSTRUCTION |
1 |
| 95 |
BLOOD BILIRUBIN ABNORMAL |
1 |
| 96 |
BLOOD GLUCOSE INCREASED |
1 |
| 97 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
| 98 |
BLOOD PRESSURE INCREASED |
1 |
| 99 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
| 100 |
BLOOD UREA INCREASED |
1 |
| 101 |
BLOOD URIC ACID INCREASED |
1 |
| 102 |
BONE PAIN |
1 |
| 103 |
BRAIN FOG |
1 |
| 104 |
BREAST CANCER |
1 |
| 105 |
C-REACTIVE PROTEIN INCREASED |
1 |
| 106 |
CARBOHYDRATE ANTIGEN 19-9 INCREASED |
1 |
| 107 |
CARDIAC ARREST |
1 |
| 108 |
CARDIAC DISORDER |
1 |
| 109 |
CARDIAC FAILURE CONGESTIVE |
1 |
| 110 |
CHEST PAIN |
1 |
| 111 |
CHOLANGITIS ACUTE |
1 |
| 112 |
CHRONIC DISEASE DECOMPENSATION |
1 |
| 113 |
COGNITIVE DISORDER |
1 |
| 114 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
| 115 |
CONTUSION |
1 |
| 116 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
| 117 |
CSF VOLUME INCREASED |
1 |
| 118 |
DEATH |
1 |
| 119 |
DECREASED INTEREST |
1 |
| 120 |
DEPRESSED MOOD |
1 |
| 121 |
DIALYSIS |
1 |
| 122 |
DRUG INTERACTION |
1 |
| 123 |
DRY EYE |
1 |
| 124 |
DRY MOUTH |
1 |
| 125 |
DRY SKIN |
1 |
| 126 |
DYSARTHRIA |
1 |
| 127 |
EMOTIONAL DISORDER |
1 |
| 128 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
1 |
| 129 |
ERUCTATION |
1 |
| 130 |
ERYTHEMA OF EYELID |
1 |
| 131 |
EYE ALLERGY |
1 |
| 132 |
EYE PAIN |
1 |
| 133 |
EYELID MARGIN CRUSTING |
1 |
| 134 |
FAECES SOFT |
1 |
| 135 |
FLATULENCE |
1 |
| 136 |
FUNGAL SKIN INFECTION |
1 |
| 137 |
GASTROINTESTINAL DISORDER |
1 |
| 138 |
GASTROINTESTINAL TUBE INSERTION |
1 |
| 139 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
| 140 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
| 141 |
HEAD DISCOMFORT |
1 |
| 142 |
HEART RATE DECREASED |
1 |
| 143 |
HEPATIC CIRRHOSIS |
1 |
| 144 |
HEPATIC ENCEPHALOPATHY |
1 |
| 145 |
HEPATIC NECROSIS |
1 |
| 146 |
HIP FRACTURE |
1 |
| 147 |
HOT FLUSH |
1 |
| 148 |
HYPERBILIRUBINAEMIA |
1 |
| 149 |
HYPERSENSITIVITY |
1 |
| 150 |
ILLNESS |
1 |
| 151 |
IMPAIRED WORK ABILITY |
1 |
| 152 |
INCONTINENCE |
1 |
| 153 |
INFLUENZA |
1 |
| 154 |
INFLUENZA LIKE ILLNESS |
1 |
| 155 |
INJECTION SITE BRUISING |
1 |
| 156 |
INJECTION SITE HAEMORRHAGE |
1 |
| 157 |
INJECTION SITE INDURATION |
1 |
| 158 |
INJECTION SITE MASS |
1 |
| 159 |
INJECTION SITE PAIN |
1 |
| 160 |
INJECTION SITE PRURITUS |
1 |
| 161 |
INTENTIONAL PRODUCT MISUSE |
1 |
| 162 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
| 163 |
JAUNDICE |
1 |
| 164 |
JOINT SWELLING |
1 |
| 165 |
LABORATORY TEST ABNORMAL |
1 |
| 166 |
LICHEN PLANUS |
1 |
| 167 |
LIGAMENT SPRAIN |
1 |
| 168 |
LIVER DISORDER |
1 |
| 169 |
LIVER FUNCTION TEST INCREASED |
1 |
| 170 |
LIVER INJURY |
1 |
| 171 |
LIVER TRANSPLANT |
1 |
| 172 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
| 173 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
| 174 |
LUMBAR VERTEBRAL FRACTURE |
1 |
| 175 |
LYME DISEASE |
1 |
| 176 |
MALAISE |
1 |
| 177 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 178 |
MOOD SWINGS |
1 |
| 179 |
MULTIPLE ALLERGIES |
1 |
| 180 |
MULTIPLE SCLEROSIS |
1 |
| 181 |
MUSCLE SPASMS |
1 |
| 182 |
MYELOFIBROSIS |
1 |
| 183 |
MYOSITIS |
1 |
| 184 |
NARCOLEPSY |
1 |
| 185 |
OCULAR DISCOMFORT |
1 |
| 186 |
OEDEMA |
1 |
| 187 |
OPHTHALMIC MIGRAINE |
1 |
| 188 |
ORAL CANDIDIASIS |
1 |
| 189 |
OSTEOPOROSIS |
1 |
| 190 |
PALPITATIONS |
1 |
| 191 |
PANCYTOPENIA |
1 |
| 192 |
PARAESTHESIA |
1 |
| 193 |
PERIORBITAL SWELLING |
1 |
| 194 |
PLATELET COUNT DECREASED |
1 |
| 195 |
PORTAL VEIN THROMBOSIS |
1 |
| 196 |
PRODUCT COMPLAINT |
1 |
| 197 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
| 198 |
PRODUCT PACKAGING QUANTITY ISSUE |
1 |
| 199 |
PRODUCT PHYSICAL ISSUE |
1 |
| 200 |
PRODUCT USE COMPLAINT |
1 |
| 201 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
| 202 |
PSORIATIC ARTHROPATHY |
1 |
| 203 |
PULMONARY EMBOLISM |
1 |
| 204 |
PYREXIA |
1 |
| 205 |
RASH MACULO-PAPULAR |
1 |
| 206 |
RASH PRURITIC |
1 |
| 207 |
RECTAL HAEMORRHAGE |
1 |
| 208 |
SENSORY DISTURBANCE |
1 |
| 209 |
SEPTIC SHOCK |
1 |
| 210 |
SKIN DISORDER |
1 |
| 211 |
SKIN LESION |
1 |
| 212 |
SKIN TIGHTNESS |
1 |
| 213 |
SLEEP DISORDER |
1 |
| 214 |
SPINAL FRACTURE |
1 |
| 215 |
SPONTANEOUS BACTERIAL PERITONITIS |
1 |
| 216 |
STEVENS-JOHNSON SYNDROME |
1 |
| 217 |
STRESS |
1 |
| 218 |
SUBDURAL HAEMATOMA |
1 |
| 219 |
SWELLING OF EYELID |
1 |
| 220 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
| 221 |
THERAPY INTERRUPTED |
1 |
| 222 |
THROMBOCYTOPENIA |
1 |
| 223 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
1 |
| 224 |
TINNITUS |
1 |
| 225 |
TREATMENT NONCOMPLIANCE |
1 |
| 226 |
UNEVALUABLE EVENT |
1 |
| 227 |
URINARY TRACT INFECTION |
1 |
| 228 |
VARICES OESOPHAGEAL |
1 |
| 229 |
VIRAL INFECTION |
1 |
| 230 |
VITREOUS FLOATERS |
1 |
| 231 |
VULVOVAGINAL DRYNESS |
1 |